Free Trial

Redhill Biopharma (RDHL) Competitors

Redhill Biopharma logo
$2.10 +0.04 (+1.94%)
Closing price 07/8/2025 03:59 PM Eastern
Extended Trading
$2.09 -0.01 (-0.48%)
As of 07/8/2025 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RDHL vs. CARM, MRKR, CTXR, RVPH, PMN, GOVX, PRPH, ALLR, HOTH, and LEXX

Should you be buying Redhill Biopharma stock or one of its competitors? The main competitors of Redhill Biopharma include Carisma Therapeutics (CARM), Marker Therapeutics (MRKR), Citius Pharmaceuticals (CTXR), Reviva Pharmaceuticals (RVPH), Promis Neurosciences (PMN), GeoVax Labs (GOVX), ProPhase Labs (PRPH), Allarity Therapeutics (ALLR), Hoth Therapeutics (HOTH), and Lexaria Bioscience (LEXX). These companies are all part of the "pharmaceutical products" industry.

Redhill Biopharma vs. Its Competitors

Carisma Therapeutics (NASDAQ:CARM) and Redhill Biopharma (NASDAQ:RDHL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends.

Carisma Therapeutics presently has a consensus target price of $1.93, indicating a potential upside of 378.86%. Given Carisma Therapeutics' stronger consensus rating and higher probable upside, research analysts plainly believe Carisma Therapeutics is more favorable than Redhill Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Carisma Therapeutics
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.43
Redhill Biopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

44.3% of Carisma Therapeutics shares are owned by institutional investors. Comparatively, 7.2% of Redhill Biopharma shares are owned by institutional investors. 12.6% of Carisma Therapeutics shares are owned by insiders. Comparatively, 6.8% of Redhill Biopharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Redhill Biopharma has a net margin of 0.00% compared to Carisma Therapeutics' net margin of -254.28%.

Company Net Margins Return on Equity Return on Assets
Carisma Therapeutics-254.28% N/A -137.38%
Redhill Biopharma N/A N/A N/A

Carisma Therapeutics has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Comparatively, Redhill Biopharma has a beta of 4.22, indicating that its stock price is 322% more volatile than the S&P 500.

In the previous week, Carisma Therapeutics had 3 more articles in the media than Redhill Biopharma. MarketBeat recorded 4 mentions for Carisma Therapeutics and 1 mentions for Redhill Biopharma. Carisma Therapeutics' average media sentiment score of 0.22 beat Redhill Biopharma's score of 0.00 indicating that Carisma Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Carisma Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Redhill Biopharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Redhill Biopharma has lower revenue, but higher earnings than Carisma Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Carisma Therapeutics$19.63M0.86-$60.48M-$1.56-0.26
Redhill Biopharma$8.04M0.60-$8.27MN/AN/A

Summary

Carisma Therapeutics beats Redhill Biopharma on 10 of the 14 factors compared between the two stocks.

Get Redhill Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RDHL vs. The Competition

MetricRedhill BiopharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$4.73M$2.44B$5.47B$8.95B
Dividend YieldN/A1.80%5.25%4.04%
P/E RatioN/A8.9826.9920.11
Price / Sales0.60724.46428.71119.81
Price / CashN/A159.8036.8257.86
Price / Book-0.574.517.985.56
Net Income-$8.27M$31.26M$3.16B$248.40M
7 Day Performance5.00%3.57%2.38%4.67%
1 Month Performance2.44%1.28%2.17%6.64%
1 Year Performance-99.06%1.08%33.81%21.31%

Redhill Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RDHL
Redhill Biopharma
N/A$2.10
+1.9%
N/A-99.0%$4.73M$8.04M0.00210
CARM
Carisma Therapeutics
2.3682 of 5 stars
$0.39
-2.2%
$1.93
+391.6%
-66.2%$16.74M$19.63M-0.2520
MRKR
Marker Therapeutics
3.797 of 5 stars
$1.53
+4.8%
$13.17
+760.6%
-65.6%$16.52M$6.59M-1.1560Positive News
Gap Up
CTXR
Citius Pharmaceuticals
2.4148 of 5 stars
$1.59
+3.9%
$53.00
+3,233.3%
-87.2%$16.27MN/A0.0020News Coverage
High Trading Volume
RVPH
Reviva Pharmaceuticals
2.2723 of 5 stars
$0.38
+12.9%
$9.00
+2,261.6%
-69.4%$16.20MN/A-0.485High Trading Volume
PMN
Promis Neurosciences
3.3559 of 5 stars
$0.48
+0.7%
$4.50
+830.1%
-79.7%$15.70MN/A-9.685Gap Up
GOVX
GeoVax Labs
3.3193 of 5 stars
$0.87
-9.8%
$11.10
+1,182.2%
-77.4%$15.29M$3.95M-0.2410
PRPH
ProPhase Labs
0.768 of 5 stars
$0.39
+6.6%
N/A-87.1%$15.25M$6.77M-0.31130
ALLR
Allarity Therapeutics
0.9645 of 5 stars
$1.01
+1.0%
N/A-83.6%$15.08MN/A0.0010
HOTH
Hoth Therapeutics
1.4161 of 5 stars
$1.17
+3.5%
$4.00
+241.9%
+44.1%$14.93MN/A-1.034
LEXX
Lexaria Bioscience
2.8462 of 5 stars
$0.87
+2.5%
$7.00
+704.6%
-65.9%$14.91M$460K-1.477Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:RDHL) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners